Home › Atopic Dermatitis (Eczema) › NCT06238765

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

Who can join

Ages 10 to 15 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* To be eligible to participate in this registry, an individual must meet all the following criteria:

  1. Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified healthcare provider
  2. Is 10 - 15 years of age at the time of enrollment.
  3. Subject has initiated or is initiating an enrollment-eligible medication at the time of enrollment

     Exclusion Criteria:
* An individual who meets any of the following criteria will be excluded from participation in the registry:

  1. Is participating or planning to participate in a blinded clinical trial for an AD drug.
  2. Is unwilling or unable to provide standing height measurements.

About the study

Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.

Sponsor: CorEvitas · Participants: 1,500 · Started: Dec 2, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06238765

Locations in the U.S.

Conditions

• Atopic Dermatitis (Eczema)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.